07 January 2022
Investor Presentation – H.C. Wainwright BIOCONNECT Virtual Conference
Shield Therapeutics plc announces that Greg Madison, Chief Executive Officer of Shield, is scheduled to present virtually at the H.C. Wainwright BIOCONNECT Virtual Conference on 10 January, 2022. Please click here for further information.